SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Arrowhead Research Corporation

ARWR XNAS
$58.16 +0.70 (+1.22%) ▲ 15-min delayed
Open
$58.21
High
$58.71
Low
$57.00
Volume
1.36M
Market Cap
$8.22B

About Arrowhead Research Corporation

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 711 Website →

Earnings & Analyst Ratings

Next Earnings: Wed, Feb 3, 2027
Calendar →

Related Market News

No specific coverage for ARWR yet. Check out our latest market news or earnings calendar.

Get ARWR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Arrowhead Research Corporation.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.